Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00430573 · ClinicalTrials.gov registry record · Phase 2
Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use
A Phase 2 study, sponsored by Boston University Charles River Campus.
- Terminated
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT00430573 is a Phase 2 study that was terminated before completion, run by Boston University Charles River Campus. The registered enrollment target is 15 participants.
The verdict
NCT00430573, a Phase 2 study, was terminated before completion, sponsored by Boston University Charles River Campus.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study examines whether isolated doses of d-cycloserine enhance the efficacy of an exposure-based cognitive-behavioral treatment for chronic and treatment refractory substance dependence.
Interventions
- DRUG Placebo
- DRUG D-cycloserine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00430573
The ClinicalTrials.gov registry entry for NCT00430573 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00430573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00430573 about?
NCT00430573 is a clinical study titled "Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use". This study examines whether isolated doses of d-cycloserine enhance the efficacy of an exposure-based cognitive-behavioral treatment for chronic and treatment refractory substance dependence.
What is the current status of trial NCT00430573?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2007-02. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00430573?
The interventions under investigation include: Placebo (DRUG), D-cycloserine (DRUG).
Who is sponsoring clinical trial NCT00430573?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.